Literature DB >> 17872860

Prescribing antidepressants to pregnant women: what is a family physician to do?

Adrienne Einarson1, Gideon Koren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17872860      PMCID： PMC2234608     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  17 in total

Review 1.  Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Authors:  Gideon Koren; Doreen Matsui; Adrienne Einarson; David Knoppert; Meir Steiner
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

2.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

Review 3.  Depression during pregnancy.

Authors:  Deirdre Ryan; Lisa Milis; Nicholas Misri
Journal:  Can Fam Physician       Date:  2005-08       Impact factor: 3.275

4.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

5.  Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Authors:  Heli Malm; Timo Klaukka; Pertti J Neuvonen
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

6.  Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.

Authors:  Thomas R Einarson; Adrienne Einarson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-12       Impact factor: 2.890

7.  Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Authors:  Sura Alwan; Jennita Reefhuis; Sonja A Rasmussen; Richard S Olney; Jan M Friedman
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

8.  Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

Authors:  Rachel Levinson-Castiel; Paul Merlob; Nehama Linder; Lea Sirota; Gil Klinger
Journal:  Arch Pediatr Adolesc Med       Date:  2006-02

Review 9.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

Review 10.  Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Authors:  Benjamin Bar-Oz; Thomas Einarson; Adrienne Einarson; Radinka Boskovic; Lisa O'Brien; Heli Malm; Anick Bérard; Gideon Koren
Journal:  Clin Ther       Date:  2007-05       Impact factor: 3.393
View more
  2 in total

Review 1.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

Review 2.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.